KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $3.4 billion.

  • Idexx Laboratories' Liabilities and Shareholders Equity rose 107.28% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 billion, marking a year-over-year decrease of 115.43%. This contributed to the annual value of $3.3 billion for FY2024, which is 102.82% up from last year.
  • Idexx Laboratories' Liabilities and Shareholders Equity amounted to $3.4 billion in Q3 2025, which was up 107.28% from $3.3 billion recorded in Q2 2025.
  • Idexx Laboratories' 5-year Liabilities and Shareholders Equity high stood at $3.4 billion for Q2 2024, and its period low was $2.3 billion during Q1 2021.
  • In the last 5 years, Idexx Laboratories' Liabilities and Shareholders Equity had a median value of $2.9 billion in 2023 and averaged $2.9 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 2338.72% in 2021, then tumbled by 416.95% in 2025.
  • Quarter analysis of 5 years shows Idexx Laboratories' Liabilities and Shareholders Equity stood at $2.4 billion in 2021, then increased by 12.7% to $2.7 billion in 2022, then grew by 18.68% to $3.3 billion in 2023, then increased by 1.03% to $3.3 billion in 2024, then increased by 2.83% to $3.4 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $3.4 billion for Q3 2025, versus $3.3 billion for Q2 2025 and $3.2 billion for Q1 2025.